Location-Aware Encoding for Lesion Detection in 68Ga-DOTATATE Positron Emission Tomography Images

IEEE Trans Biomed Eng. 2024 Jan;71(1):247-257. doi: 10.1109/TBME.2023.3297249. Epub 2023 Dec 22.

Abstract

Objective: Lesion detection with positron emission tomography (PET) imaging is critical for tumor staging, treatment planning, and advancing novel therapies to improve patient outcomes, especially for neuroendocrine tumors (NETs). Current lesion detection methods often require manual cropping of regions/volumes of interest (ROIs/VOIs) a priori, or rely on multi-stage, cascaded models, or use multi-modality imaging to detect lesions in PET images. This leads to significant inefficiency, high variability and/or potential accumulative errors in lesion quantification. To tackle this issue, we propose a novel single-stage lesion detection method using only PET images.

Methods: We design and incorporate a new, plug-and-play codebook learning module into a U-Net-like neural network and promote lesion location-specific feature learning at multiple scales. We explicitly regularize the codebook learning with direct supervision at the network's multi-level hidden layers and enforce the network to learn multi-scale discriminative features with respect to predicting lesion positions. The network automatically combines the predictions from the codebook learning module and other layers via a learnable fusion layer.

Results: We evaluate the proposed method on a real-world clinical 68Ga-DOTATATE PET image dataset, and our method produces significantly better lesion detection performance than recent state-of-the-art approaches.

Conclusion: We present a novel deep learning method for single-stage lesion detection in PET imaging data, with no ROI/VOI cropping in advance, no multi-stage modeling and no multi-modality data.

Significance: This study provides a new perspective for effective and efficient lesion identification in PET, potentially accelerating novel therapeutic regimen development for NETs and ultimately improving patient outcomes including survival.

MeSH terms

  • Gallium Radioisotopes
  • Humans
  • Neuroendocrine Tumors* / pathology
  • Organometallic Compounds*
  • Positron-Emission Tomography / methods

Substances

  • copper dotatate CU-64
  • Gallium Radioisotopes
  • Organometallic Compounds